ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

The NLST at a Glance

August 2, 2013

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002

NCI To Expand SPORE Grants Program to Increase Translational Research Funding

October 22, 1999

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002